Medication Adherence In Patients With Arterial Hypertension: The Relationship With Healthcare Systems’ Organizational Factors

References

• No authors listed. Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018.
   Google Scholar
• Zhou B, Bentham J, Di Cesare M, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19,1 million participants. Lancet. 2017;389(10064):37–55. doi:10.1016/S0140-6736(16)31919-527863813
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy33930165516
   PubMed Web of Science ®Google Scholar
• Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
   Google Scholar
• de Oliveira A, Santos P. Hypertension: drug adherence and social factors. J Hyper-Tens Manag. 2018;4:034.
   Google Scholar
• Gupta P, Patel P, Horne R, Buchanan H, Williams B, Tomaszewski M. How to screen for non-adherence to antihypertensive therapy. Curr Hypertens Rep. 2016;18(12). doi:10.1007/s11906-016-0697-7
   Web of Science ®Google Scholar
• Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S. Drug adherence in hypertension: from methodological issues to cardiovascular outcomes. J Hypertens. 2017;35(6):1133–1144. doi:10.1097/HJH.000000000000129928306634
   PubMed Web of Science ®Google Scholar
• AlGhurair SA, Hughes CA, Simpson SH, Guirguis LM. A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model. J Clin Hypertens (Greenwich). 2012;14(12):877–886. doi:10.1111/j.1751-7176.2012.00699.x23205755
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-000073945130
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra05010016079372
   PubMed Web of Science ®Google Scholar
• Santos P. Challenge of health literacy in cardiovascular disease prevention. J Heart Res. 2018;1(1):1.
   Google Scholar
• Wilson A, Childs S. The relationship between consultation length, process and outcomes in general practice: a systematic review. Br J Gen Pract. 2002;52(485):1012–1020.12528590
   PubMed Web of Science ®Google Scholar
• Irving G, Neves AL, Dambha-Miller H, et al. International variations in primary care physician consultation time: a systematic review of 67 countries. BMJ Open. 2017;7(10):e017902. doi:10.1136/bmjopen-2017-017902
   PubMed Web of Science ®Google Scholar
• NIH. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools Assessed November 14, 2018.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b265119622551
   PubMed Web of Science ®Google Scholar
• Mc Namara KP, Versace VL, Marriott JL, Dunbar JA. Patient engagement strategies used for hypertension and their influence on self-management attributes. Fam Pract. 2014;31(4):437–444. doi:10.1093/fampra/cmu02624895137
   PubMed Web of Science ®Google Scholar
• Morrison VL, Holmes EAF, Parveen S, et al. Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey. Value Health. 2015;18(2):206–216. doi:10.1016/j.jval.2014.12.01325773556
   PubMed Web of Science ®Google Scholar
• Khanam MA, Lindeboom W, Koehlmoos TLP, Alam DS, Niessen L, Milton AH. Hypertension: adherence to treatment in rural Bangladesh - findings from a population-based study. Glob Health Action. 2014;7(1). doi:10.3402/gha.v7.25484
   Web of Science ®Google Scholar
• MdS B, Cremonese IZ, Janeiro V, Matsuda LM, Marcon SS. Prevalência de não adesão à farmacoterapia anti-hipertensiva e fatores associados. Rev Bras Enferm. 2015;68(1):60–67. doi:10.1590/0034-7167.2015680109p
   Google Scholar
• Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky-Green test to evaluate medication adherence. Rev Saude Publica. 2012;46(2):279–289. doi:10.1590/s0034-8910201200500001322331180
   PubMed Web of Science ®Google Scholar
• Bezerra AS, Lopes J, de Barros AL. Adherence of hypertensive patients to drug treatment. Rev Bras Enferm. 2014;67(4):550–555. doi:10.1590/0034-7167.201467040825271578
   PubMedGoogle Scholar
• Carvalho ALM, Leopoldino RWD, JEG DS, da Cunha CP. Adherence to drug treatment among registered users in the “HIPERDIA” program in Teresina in the State of Piauí. Cienc Saude Coletiva. 2012;17(7):1885–1892. doi:10.1590/S1413-81232012000700028
   Web of Science ®Google Scholar
• de Oliveira-Filho AD, Morisky DE, Neves SJF, Costa FA, De Lyra DP. The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Soc Adm Pharm. 2014;10(3):554–561. doi:10.1016/j.sapharm.2013.10.006
   PubMed Web of Science ®Google Scholar
• de Santa-Helena ET, Nemes MIB, Neto JE. Risk factors associated with non-adherence to anti-hypertensive medication among patients treated in family healthcare facilities. Cad Saude Publica. 2010;26(12):2389–2398. doi:10.1590/s0102-311x201000120001721243233
   PubMed Web of Science ®Google Scholar
• Demoner MS, ERdP R, Pereira ER. Factors associated with adherence to antihypertensive treatment in a primary care unit. Acta Paul Enferm. 2012;25(spe1):27–34. doi:10.1590/S0103-21002012000800005
   Web of Science ®Google Scholar
• Magnabosco P, Teraoka EC, De Oliveira EM, Felipe EA, Freitas D, Marchi-Alves LM. Comparative analysis of non-adherence to medication treatment for systemic arterial hypertension in urban and rural populations. Rev Lat Am Enfermagem. 2015;23(1):20–27. doi:10.1590/0104-1169.0144.252025806627
   PubMed Web of Science ®Google Scholar
• Oliveira-Filho AD, Barreto-Filho JA, Neves SJF, de Lyra DP Jr. Association between the 8-item Morisky Medication adherence Scale (MMAS-8) and blood pressure control. Arq Bras Cardiol. 2012;99(1):649–658. doi:10.1590/s0066-782x201200500005322688844
   PubMed Web of Science ®Google Scholar
• Ungari AQ, Fabbro ALD. Adherence to drug treatment in hypertensive patients on the family health program. Braz J Pharm Sci. 2010;46(4):811–818. doi:10.1590/S1984-82502010000400024
   Web of Science ®Google Scholar
• Evans CD, Eurich DT, Remillard AJ, Shevchuk YM, Blackburn D. First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study. Am J Hypertens. 2012;25(2):195–203. doi:10.1038/ajh.2011.19822089108
   PubMed Web of Science ®Google Scholar
• Ma C. A cross-sectional survey of medication adherence and associated factors for rural patients with hypertension. Appl Nurs Res. 2016;31:94–99. doi:10.1016/j.apnr.2016.01.00427397825
   PubMed Web of Science ®Google Scholar
• Strand MA, Gramith K, Royston M, Wang X, Perry J, Elliott C. A community-based cross-sectional survey of medication utilization among chronic disease patients in China. Int J Pharm Pract. 2017;25(5):371–378. doi:10.1111/ijpp.1232727896880
   PubMed Web of Science ®Google Scholar
• Yang S, He C, Zhang X, et al. Determinants of antihypertensive adherence among patients in Beijing: application of the health belief model. Patient Educ Couns. 2016;99(11):1894–1900. doi:10.1016/j.pec.2016.06.01427378081
   PubMed Web of Science ®Google Scholar
• Yue Z, Bin W, Weilin Q, Aifang Y. Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence. J Eval Clin Pract. 2015;21(1):166–172. doi:10.1111/jep.1226825318567
   PubMed Web of Science ®Google Scholar
• Ambaw AD, Alemie GA, Wyohannes SM, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012;12(1). doi:10.1186/1471-2458-12-282
   Web of Science ®Google Scholar
• Berhe DF, Taxis K, Haaijer-Ruskamp FM, et al. Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication – a study in ambulatory patients. Br J Clin Pharmacol. 2017;83(9):2107–2117. doi:10.1111/bcp.1331228429533
   PubMed Web of Science ®Google Scholar
• Mekonnen HS, Gebrie MH, Eyasu KH, Gelagay AA. Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. BMC Pharmacol Toxicol. 2017;18(1). doi:10.1186/s40360-017-0134-9
   Web of Science ®Google Scholar
• Nabi H, Vahtera J, Singh-Manoux A, et al. Do psychological attributes matter for adherence to antihypertensive medication the Finnish Public Sector Cohort Study. J Hypertens. 2008;26(11):2236–2243. doi:10.1097/HJH.0b013e32830dfe5f18854766
   PubMed Web of Science ®Google Scholar
• Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients. J Hypertens. 2017;35(9):1891–1898. doi:10.1097/HJH.000000000000140228505066
   PubMed Web of Science ®Google Scholar
• Korb-Savoldelli V, Gillaizeau F, Pouchot J, et al. Validation of a French Version of the 8-Item Morisky Medication Adherence Scale in Hypertensive Adults. J Clin Hypertens. 2012;14(7):429–434. doi:10.1111/j.1751-7176.2012.00634.x
   PubMed Web of Science ®Google Scholar
• Ude M, Leuner K, Schüssel K, Schulz M, Müller WE. Adherence to antihypertensives: feasibility of two self-report instruments to investigate medication-taking behavior in German community pharmacies. Int J Pharm Pract. 2013;21(3):169–177. doi:10.1111/j.2042-7174.2012.00248.x23419034
   PubMedGoogle Scholar
• Van De Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary healthcare setting. J Eval Clin Pract. 2009;15(3):468–472. doi:10.1111/j.1365-2753.2008.01038.x19366389
   PubMed Web of Science ®Google Scholar
• Kang CD, Tsang PPM, Li WTL, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol. 2015;182(C):250–257. doi:10.1016/j.ijcard.2014.12.06425585359
   PubMed Web of Science ®Google Scholar
• Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One. 2013;8(4):e62775. doi:10.1371/journal.pone.006277523638143
   PubMed Web of Science ®Google Scholar
• Doró P, Benko R, Czakó A, Matuz M, Thurzó F, Soós G. Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study. Int J Clin Pharm. 2011;33(4):690–695. doi:10.1016/j.ihj.2016.08.00321691882
   PubMed Web of Science ®Google Scholar
• Choudhary R, Sharma SM, Kumari V, Gautam D. Awareness, treatment adherence and risk predictors of uncontrolled hypertension at a tertiary care teaching hospital in Western India. Indian Heart J. 2016;68:S251–S252. doi:10.1016/j.ihj.2016.08.00327751307
   PubMedGoogle Scholar
• Dennis T, Meera NK, Binny K, Sekhar MS, Kishore G, Sasidharan S. Medication adherence and associated barriers in hypertension management in India. CVD Prev Contr. 2011;6(1):9–13. doi:10.1016/j.cvdpc.2010.11.001
   Google Scholar
• Sulistiyowatiningsih E, Herawati M. A multicenter study treatment adherence of hypertension focused on primary healthcare in Indonesia. Asian J Pharm Clin Res. 2017;10(SpecialIssue August):24–27. doi:10.22159/ajpcr.2017v10s3.21356
   Google Scholar
• Behnood-Rod A, Rabbanifar O, Pourzargar P, et al. Adherence to Antihypertensive Medications in Iranian Patients. Int J Hypertens. 2016;2016:1–7. doi:10.1155/2016/1508752
   Web of Science ®Google Scholar
• Moharamzad Y, Saadat H, Nakhjavan Shahraki B, et al. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci. 2015;7(4):173–183. doi:10.5539/gjhs.v7n4p17325946926
   PubMedGoogle Scholar
• Al-Daken LI, Eshah NF. Self-reported adherence to therapeutic regimens among patients with hypertension. Clin Exp Hypertens. 2017;39(3):264–270. doi:10.1080/10641963.2016.124716428448187
   PubMed Web of Science ®Google Scholar
• Bhandari B, Bhattarai M, Bhandari M, Ghimire A, Pokharel PK, Morisky DE. Adherence to Antihypertensive medications: population based follow up in Eastern Nepal. J Nepal Health Res Counc. 2015;13(29):38–42.26411711
   PubMedGoogle Scholar
• Van Onzenoort HAW, Verberk WJ, Kessels AGH, et al. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. Am J Hypertens. 2010;23(2):149–154. doi:10.1038/ajh.2009.20719927136
   PubMed Web of Science ®Google Scholar
• Adeyemo A, Tayo BO, Luke A, Ogedegbe O, Durazo-Arvizu R, Cooper RS. The Nigerian antihypertensive adherence trial: a community-based randomized trial. J Hypertens. 2013;31(1):201–207. doi:10.1097/HJH.0b013e32835b084223137954
   PubMed Web of Science ®Google Scholar
• Iloh GUP, Ofoedu JN, Njoku PU, Amadi AN, Godswill-Uko EU. Medication adherence and blood pressure control amongst adults with primary hypertension attending a tertiary hospital primary care clinic in Eastern Nigeria. Afr J Prim Health Care Fam Med. 2013;5(1):446. doi:10.4102/phcfm.v5i1.446
   Google Scholar
• Okwuonu CG, Ojimadu NE, Okaka EI, Akemokwe FM. Patient-related barriers to hypertension control in a Nigerian population. Int J Gen Med. 2014;7:345–353. doi:10.2147/IJGM.S6358725061335
   PubMedGoogle Scholar
• Okwuonu CG, Uwanurochi NV, Chimezie OJ, Ogah OS, Mbanaso AU, Odigwe CO. Adherence to antihypertensive medication and its correlates among individuals with hypertension in a Semi-Urban community of Southern Nigeria. J Med Biomed Res. 2015;14(1):5–17.
   Google Scholar
• Arshad AR. Frequency of poor adherence to antihypertensive treatment and an analysis of clinico-demographic correlates. J Coll Phys Surg Pak. 2015;25(12):911–913.
   Web of Science ®Google Scholar
• Hashmi SK, Afridi MB, Abbas K, et al. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLoS One. 2007;2(3):e280. doi:10.1371/journal.pone.000028017356691
   PubMed Web of Science ®Google Scholar
• Saleem F, Hassali MA, Shafie AA, et al. Does treatment adherence correlates with health related quality of life? findings from a cross sectional study. BMC Public Health. 2012;12(1). doi:10.1186/1471-2458-12-318.
   Web of Science ®Google Scholar
• Rodríguez-Abt JC, Solís-Visscher RJ, Rogic-Valencia SJ, Román Y, Reyes-Rocha M. Association between hypertension awareness and treatment adherence in hypertensive Patients at Hospital Nacional Edgardo Rebagliati Martins in Lima, Perú, 2015. Rev Fac Med. 2017;65(1):55–60. doi:10.15446/revfacmed.v65n1.56773
   Google Scholar
• Jankowska-Polanska B, Uchmanowicz I, Chudiak A, Dudek K, Morisky DE, Szymanska-Chabowska A. Psychometric properties of the polish version of the eight-item morisky medication adherence scale in hypertensive adults. Patient Prefer Adherence. 2016;10:1759–1766. doi:10.2147/PPA.S10190427672314
   PubMed Web of Science ®Google Scholar
• Wiliński J, Dabrowski M. Medication adherence in hypertensive patients of different cardiovascular risk treated in primary healthcare. Prz Lek. 2013;70(6):377–380.24052973
   PubMedGoogle Scholar
• da Costa FA, Pedro AR, Teixeira I, Bragança F, da Silva JA, Cabrita J. Primary non-adherence in Portugal: findings and implications. Int J Clin Pharm. 2015;37(4):626–635. doi:10.1007/s11096-015-0108-125832675
   PubMed Web of Science ®Google Scholar
• Baena-Díez JM, Gómez-Fernández C, Vilató-García M, Vásquez-Lazo EJ, Byram AO, Vidal-Solsona M. A prescription register incorporated into computerized medical records for patients with hypertension: a new instrument to evaluate medication adherence. Aten Prim. 2011;43(7):336–342. doi:10.1016/j.aprim.2010.04.018
   Web of Science ®Google Scholar
• Calderón-Larrañaga A, Diaz E, Poblador-Plou B, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A. Non-adherence to antihypertensive medication: the role of mental and physical comorbidity. Int J Cardiol. 2016;207:310–316. doi:10.1016/j.ijcard.2016.01.06926814635
   PubMed Web of Science ®Google Scholar
• Omar SM, Elnour O, Adam GK, Osman OE, Adam I. Assessment of blood pressure control in adult hypertensive patients in eastern Sudan. BMC Cardiovasc Disord. 2018;18(1). doi:10.1186/s12872-018-0939-5
   Web of Science ®Google Scholar
• Qvarnström M, Kahan T, Kieler H, et al. Persistence to antihypertensive drug treatment in Swedish primary healthcare. Eur J Clin Pharmacol. 2013;69(11):1955–1964. doi:10.1007/s00228-013-1555-z23857249
   PubMed Web of Science ®Google Scholar
• Karaeren H, Yokuşoğlu M, Ş U, et al. The effect of the content of the knowledge on adherence to medication in hypertensive patients. Anatol J Cardiol. 2009;9:183–189.
   Web of Science ®Google Scholar
• Karakurt P, Kaşikçi M. Factors affecting medication adherence in patients with hypertension. J Vasc Nurs. 2012;30(4):118–126. doi:10.1016/j.jvn.2012.04.00223127428
   PubMedGoogle Scholar
• Bader RJK, Koprulu F, Hassan NAGM, Ali AAA, Elnour AA. Predictors of adherence to antihypertensive medication in northern United Arab Emirates. East Mediterr Health J. 2015;21(5):309–318.26343119
   PubMed Web of Science ®Google Scholar
• Fahey M, Abdulmajeed A, Sabra K. Measurement of adherence to anti-hypertensive medication as perceived by doctors and patients. Qatar Med J. 2006;15(1).
   Google Scholar
• Horne R, Clatworthy J, Hankins M. High adherence and concordance within a clinical trial of antihypertensives. Chronic Illn. 2010;6(4):243–251. doi:10.1177/174239531036901820610466
   PubMedGoogle Scholar
• Fortuna RJ, Nagel AK, Rocco TA, Legette-Sobers S, Quigley DD. Patient experience with care and its association with adherence to hypertension medications. Am J Hypertens. 2018;31(3):340–345. doi:10.1093/ajh/hpx20029253071
   PubMed Web of Science ®Google Scholar
• Grigoryan L, Pavlik VN, Hyman DJ. Predictors of antihypertensive medication adherence in two urban health-care systems. Am J Hypertens. 2012;25(7):735–738. doi:10.1038/ajh.2012.3022441507
   PubMed Web of Science ®Google Scholar
• Haley WE, Gilbert ON, Riley RF, et al. The association between self-reported medication adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens. 2016;10(11):857–864.e852. doi:10.1016/j.jash.2016.08.00927697447
   PubMed Web of Science ®Google Scholar
• Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Managed Care. 2010;16(8):568–576.
   PubMed Web of Science ®Google Scholar
• Roberts AW, Crisp GD, Esserman DA, Roth MT, Weinberger M, Farley JF. Patterns of medication adherence and healthcare utilization among patients with chronic disease who were enrolled in a pharmacy assistance program. N C Med J. 2014;75(5):310–318.25237868
   PubMedGoogle Scholar
• Whittle J, Yamal JM, Williamson JD, et al. Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trial. BMC Health Serv Res. 2016;16(1). doi:10.1186/s12913-016-1471-x.
   Web of Science ®Google Scholar
• Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–1196. doi:10.1016/j.amjhyper.2006.04.00617070434
   PubMed Web of Science ®Google Scholar
• Dantas R, JPTd S, DCdO D, Roncalli ÂG. Factors associated with hospital admissions due to hypertension. Einstein (Sao Paulo). 2018;16(3):eAO4283–eAO4283. doi:10.1590/S1679-45082018AO428330281763
   PubMed Web of Science ®Google Scholar